<?xml version='1.0' encoding='utf-8'?>
<document id="25016073"><sentence text="PEPT1- and OAT1/3-mediated drug-drug interactions between bestatin and cefixime in vivo and in vitro in rats, and in vitro in human."><entity charOffset="58-66" id="DDI-PubMed.25016073.s1.e0" text="bestatin" /><entity charOffset="71-79" id="DDI-PubMed.25016073.s1.e1" text="cefixime" /><pair ddi="false" e1="DDI-PubMed.25016073.s1.e0" e2="DDI-PubMed.25016073.s1.e0" /><pair ddi="false" e1="DDI-PubMed.25016073.s1.e0" e2="DDI-PubMed.25016073.s1.e1" /></sentence><sentence text="The purpose of the present study was to elucidate the transporter-mediated pharmacokinetics mechanism of drug-drug interactions (DDIs) between bestatin and cefixime"><entity charOffset="143-151" id="DDI-PubMed.25016073.s2.e0" text="bestatin" /><entity charOffset="156-164" id="DDI-PubMed.25016073.s2.e1" text="cefixime" /><pair ddi="false" e1="DDI-PubMed.25016073.s2.e0" e2="DDI-PubMed.25016073.s2.e0" /><pair ddi="false" e1="DDI-PubMed.25016073.s2.e0" e2="DDI-PubMed.25016073.s2.e1" /></sentence><sentence text=" The plasma concentrations and bioavailabilities of bestatin and cefixime were decreased after oral co-administration in rats"><entity charOffset="52-60" id="DDI-PubMed.25016073.s3.e0" text="bestatin" /><entity charOffset="65-73" id="DDI-PubMed.25016073.s3.e1" text="cefixime" /><pair ddi="false" e1="DDI-PubMed.25016073.s3.e0" e2="DDI-PubMed.25016073.s3.e0" /><pair ddi="false" e1="DDI-PubMed.25016073.s3.e0" e2="DDI-PubMed.25016073.s3.e1" /></sentence><sentence text=" The uptake in rat everted intestinal sacs of bestatin and cefixime were dramatically declined after co-administration of the two drugs"><entity charOffset="46-54" id="DDI-PubMed.25016073.s4.e0" text="bestatin" /><entity charOffset="59-67" id="DDI-PubMed.25016073.s4.e1" text="cefixime" /><pair ddi="false" e1="DDI-PubMed.25016073.s4.e0" e2="DDI-PubMed.25016073.s4.e0" /><pair ddi="false" e1="DDI-PubMed.25016073.s4.e0" e2="DDI-PubMed.25016073.s4.e1" /></sentence><sentence text=" Bestatin and cefixime can mutually competitively inhibit the uptake by hPEPT1-HeLa cells"><entity charOffset="1-9" id="DDI-PubMed.25016073.s5.e0" text="Bestatin" /><entity charOffset="14-22" id="DDI-PubMed.25016073.s5.e1" text="cefixime" /><pair ddi="false" e1="DDI-PubMed.25016073.s5.e0" e2="DDI-PubMed.25016073.s5.e0" /><pair ddi="false" e1="DDI-PubMed.25016073.s5.e0" e2="DDI-PubMed.25016073.s5.e1" /></sentence><sentence text=" The plasma concentrations of bestatin and cefixime were increased; however, the cumulative biliary excretion had no significant change, and the cumulative urinary excretion and renal clearance of the two drugs in rats decreased after intravenous coadministration"><entity charOffset="30-38" id="DDI-PubMed.25016073.s6.e0" text="bestatin" /><entity charOffset="43-51" id="DDI-PubMed.25016073.s6.e1" text="cefixime" /><pair ddi="false" e1="DDI-PubMed.25016073.s6.e0" e2="DDI-PubMed.25016073.s6.e0" /><pair ddi="false" e1="DDI-PubMed.25016073.s6.e0" e2="DDI-PubMed.25016073.s6.e1" /></sentence><sentence text=" Moreover, decreased uptake of the two drugs was observed in human kidney slices, rat kidney slices and hOAT1/hOAT3-transfected HEK293 cells when bestatin and cefixime were coadministered"><entity charOffset="146-154" id="DDI-PubMed.25016073.s7.e0" text="bestatin" /><entity charOffset="159-167" id="DDI-PubMed.25016073.s7.e1" text="cefixime" /><pair ddi="false" e1="DDI-PubMed.25016073.s7.e0" e2="DDI-PubMed.25016073.s7.e0" /><pair ddi="false" e1="DDI-PubMed.25016073.s7.e0" e2="DDI-PubMed.25016073.s7.e1" /></sentence><sentence text=" The accumulation of bestatin and cefixime in kidney slices can be inhibited by p-aminohippurate, benzylpenicillin and probenecid, but not by tetraethyl ammonium"><entity charOffset="21-29" id="DDI-PubMed.25016073.s8.e0" text="bestatin" /><entity charOffset="34-42" id="DDI-PubMed.25016073.s8.e1" text="cefixime" /><entity charOffset="80-96" id="DDI-PubMed.25016073.s8.e2" text="p-aminohippurate" /><entity charOffset="98-114" id="DDI-PubMed.25016073.s8.e3" text="benzylpenicillin" /><entity charOffset="119-129" id="DDI-PubMed.25016073.s8.e4" text="probenecid" /><entity charOffset="142-161" id="DDI-PubMed.25016073.s8.e5" text="tetraethyl ammonium" /><pair ddi="false" e1="DDI-PubMed.25016073.s8.e0" e2="DDI-PubMed.25016073.s8.e0" /><pair ddi="false" e1="DDI-PubMed.25016073.s8.e0" e2="DDI-PubMed.25016073.s8.e1" /><pair ddi="false" e1="DDI-PubMed.25016073.s8.e0" e2="DDI-PubMed.25016073.s8.e2" /><pair ddi="false" e1="DDI-PubMed.25016073.s8.e0" e2="DDI-PubMed.25016073.s8.e3" /><pair ddi="false" e1="DDI-PubMed.25016073.s8.e0" e2="DDI-PubMed.25016073.s8.e4" /><pair ddi="false" e1="DDI-PubMed.25016073.s8.e0" e2="DDI-PubMed.25016073.s8.e5" /><pair ddi="false" e1="DDI-PubMed.25016073.s8.e1" e2="DDI-PubMed.25016073.s8.e1" /><pair ddi="false" e1="DDI-PubMed.25016073.s8.e1" e2="DDI-PubMed.25016073.s8.e2" /><pair ddi="false" e1="DDI-PubMed.25016073.s8.e1" e2="DDI-PubMed.25016073.s8.e3" /><pair ddi="false" e1="DDI-PubMed.25016073.s8.e1" e2="DDI-PubMed.25016073.s8.e4" /><pair ddi="false" e1="DDI-PubMed.25016073.s8.e1" e2="DDI-PubMed.25016073.s8.e5" /><pair ddi="false" e1="DDI-PubMed.25016073.s8.e2" e2="DDI-PubMed.25016073.s8.e2" /><pair ddi="false" e1="DDI-PubMed.25016073.s8.e2" e2="DDI-PubMed.25016073.s8.e3" /><pair ddi="false" e1="DDI-PubMed.25016073.s8.e2" e2="DDI-PubMed.25016073.s8.e4" /><pair ddi="false" e1="DDI-PubMed.25016073.s8.e2" e2="DDI-PubMed.25016073.s8.e5" /><pair ddi="false" e1="DDI-PubMed.25016073.s8.e3" e2="DDI-PubMed.25016073.s8.e3" /><pair ddi="false" e1="DDI-PubMed.25016073.s8.e3" e2="DDI-PubMed.25016073.s8.e4" /><pair ddi="false" e1="DDI-PubMed.25016073.s8.e3" e2="DDI-PubMed.25016073.s8.e5" /><pair ddi="false" e1="DDI-PubMed.25016073.s8.e4" e2="DDI-PubMed.25016073.s8.e4" /><pair ddi="false" e1="DDI-PubMed.25016073.s8.e4" e2="DDI-PubMed.25016073.s8.e5" /></sentence><sentence text=" The results suggest that intestinal absorption and renal excretion of bestatin and cefixime can be inhibited when the two drugs were co-administered in rats"><entity charOffset="71-79" id="DDI-PubMed.25016073.s9.e0" text="bestatin" /><entity charOffset="84-92" id="DDI-PubMed.25016073.s9.e1" text="cefixime" /><pair ddi="false" e1="DDI-PubMed.25016073.s9.e0" e2="DDI-PubMed.25016073.s9.e0" /><pair ddi="false" e1="DDI-PubMed.25016073.s9.e0" e2="DDI-PubMed.25016073.s9.e1" /></sentence><sentence text=" The pharmacokinetic mechanism indicates that the DDIs between bestatin and cefixime are mainly mediated by Pept1 and Oat1/3 in rats"><entity charOffset="63-71" id="DDI-PubMed.25016073.s10.e0" text="bestatin" /><entity charOffset="76-84" id="DDI-PubMed.25016073.s10.e1" text="cefixime" /><pair ddi="false" e1="DDI-PubMed.25016073.s10.e0" e2="DDI-PubMed.25016073.s10.e0" /><pair ddi="false" e1="DDI-PubMed.25016073.s10.e0" e2="DDI-PubMed.25016073.s10.e1" /></sentence><sentence text=" PEPT1 and OAT1/3 are the target transporters of DDIs between bestatin and cefixime in human kidney slices and human transfected cells, proposing possible drug-drug interaction in humans"><entity charOffset="62-70" id="DDI-PubMed.25016073.s11.e0" text="bestatin" /><entity charOffset="75-83" id="DDI-PubMed.25016073.s11.e1" text="cefixime" /><pair ddi="false" e1="DDI-PubMed.25016073.s11.e0" e2="DDI-PubMed.25016073.s11.e0" /><pair ddi="false" e1="DDI-PubMed.25016073.s11.e0" e2="DDI-PubMed.25016073.s11.e1" /></sentence><sentence text=" " /></document>